BRIDGEWATER, N.J., July 30 /PRNewswire/ -- Wolters Kluwer Health, a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry, today launched an enhanced version of AdisOnline (http://adisonline.com), providing a host of user-customizable features and purchasing options that help keep healthcare professionals better informed about drug development and therapy.
"Our content hasn't changed, we still publish the industry's most trusted drug evaluations with must-have drug research and news, but now it's available in new ways," said Iain Spray, Adis Product Manager, Wolters Kluwer Health. "The new AdisOnline gives users more flexibility in how customers access and pay for content that is more in tune with their needs."
According to Spray, purchasing behavior in the world of medical journals is starting to mirror the trends in popular media. "Our customers can now access a wide choice of new content packages on a pay-per-view basis," continued Spray. "This novel bundling method offers exceptional value for customers who don't necessarily need all the content in a conventional subscription."
Increases Options for Obtaining Journal Content
AdisOnline has been enhanced to meet the changing market needs of a growing number of clinicians, researchers and librarians seeking means to greater efficiency. "AdisOnline's new personalization capabilities and pricing-models allow users to identify relevant information faster without having to purchase anything superfluous," said Ingrid Young, Adis Marketing Manager, Wolters Kluwer Health.
AdisOnline users can now access "themed article collections" of varying sizes covering topics such as Diabetes, Urology, Clinical Trial Methodology, Data Mining, Ethics, and Drug Evaluations.
"We continue to offer subscription access to our journals and newsletters, but we also offer pay-per-view access to collections of articles drawn from titles across the Adis journal portfolio, grouped by niche areas of interest," said Young.
Relevant articles from all of the Adis journals are selected regularly by Adis editors and posted in each of the themed collection areas. Customers can access the full-text HTML and all of the rich media associated with any of the papers in each collection on a pay-per-view basis. The price per article in a collection is significantly less than the price of articles bought individually.
AdisOnline users also can access:
The Adis portfolio of 24 journals, newsletters and local editions features many of the leading journals on drug development, therapy and pharmacoevaluation including titles such as Drugs, Drug Safety, PharmacoEconomics and The Patient: Patient-centered Outcomes Research.
About Wolters Kluwer Health
Wolters Kluwer Health (Philadelphia, PA) is a leading provider of information and business intelligence for students, professionals and institutions in medicine, nursing, allied health, pharmacy and the pharmaceutical industry. Major brands include traditional publishers of medical and drug reference tools and textbooks, such as Lippincott Williams & Wilkins and Facts & Comparisons(R); electronic information providers, such as Ovid, UpToDate(R), Medi-Span(R) and ProVation(R) Medical; and pharmaceutical information providers such as Adis International and Source(R).
Wolters Kluwer Health is a division of Wolters Kluwer, a leading global information services and publishing company. The company provides products and services for professionals in the health, tax, accounting, corporate, financial services, legal, and regulatory sectors. Wolters Kluwer had 2008 annual revenues of euro 3.4 billion ($4.9 billion), employs approximately 20,000 people worldwide, and maintains operations in over 35 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Amsterdam, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Visit www.wolterskluwer.com for information about our market positions, customers, brands, and organization.
Contact: Tom Kivett Kivett & Company Communications (212) 727-2935 email@example.com
|SOURCE Wolters Kluwer Health Pharma Solutions|
Copyright©2009 PR Newswire.
All rights reserved